| Trial |
X1 |
X2 |
X3 |
EC (%) |
PC (%) |
RED (%) |
| 1 |
1:15 |
45 |
0.1 |
12.4 |
10.0 |
19.0 |
| 2 |
1:4.5 |
45 |
0.1 |
30.3 |
31.3 |
3.3 |
| 3 |
1:1.5 |
65 |
0.1 |
37.0 |
40.9 |
10.5 |
| 4 |
1:4.5 |
65 |
0.1 |
60.0 |
62. |
3.6 |
| 5 |
1:1.5 |
45 |
0.3 |
52.6 |
48.9 |
6.9 |
| 6 |
1:4.5 |
45 |
0.3 |
65.2 |
70.2 |
7.7 |
| 7 |
1:1.5 |
65 |
0.3 |
80.4 |
79.8 |
0.8 |
| 8 |
1:4.5 |
65 |
0.3 |
96.9 |
101.1 |
4.3 |
| 9 |
1:0.48 |
55 |
0.2 |
27.9 |
30.7 |
10.0 |
| 10 |
1:5.52 |
55 |
0.2 |
72.6 |
66.4 |
8.5 |
| 11 |
1:3 |
38 |
0.2 |
40.2 |
41.4 |
2.9 |
| 12 |
1:3 |
72 |
0.2 |
97.7 |
93.2 |
4.6 |
| 13 |
1:3 |
55 |
0.03 |
24.9 |
23.3 |
6.5 |
| 14 |
1:3 |
55 |
0.37 |
90.4 |
88.6 |
1.9 |
| 15 |
1:3 |
55 |
0.2 |
84.3 |
84.4 |
0.2 |
| 16 |
1:3 |
55 |
0.2 |
84.3 |
84.4 |
0.3 |
| 17 |
1:3 |
55 |
0.2 |
84.2 |
84.4 |
0.3 |
|
| a Relative Error Deviation (RED)=|(EC-EP)/EC| × 100. |
| Table 4: Matrix of the Central Composite Rotatable Design 23 (CCRD) with
responses in terms of eugenyl acetate conversion. |
